BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8925851)

  • 1. Technetium-99m hexamethylpropylene amine oxime single-photon emission tomography of regional cerebral blood flow in insulin-dependent diabetes.
    Keymeulen B; de Metz K; Cluydts R; Bossuyt A; Somers G
    Eur J Nucl Med; 1996 Feb; 23(2):163-8. PubMed ID: 8925851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional cerebral hypoperfusion in long-term type 1 (insulin-dependent) diabetic patients: relation to hypoglycaemic events.
    Keymeulen B; Jacobs A; de Metz K; de Sadeleer C; Bossuyt A; Somers G
    Nucl Med Commun; 1995 Jan; 16(1):10-6. PubMed ID: 7609929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive measurements of regional cerebral blood flow using technetium-99m hexamethylpropylene amine oxime.
    Matsuda H; Tsuji S; Shuke N; Sumiya H; Tonami N; Hisada K
    Eur J Nucl Med; 1993 May; 20(5):391-401. PubMed ID: 8519258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional cerebral blood flow pattern in normal young and aged volunteers: a 99mTc-HMPAO SPET study.
    Catafau AM; Lomeña FJ; Pavia J; Parellada E; Bernardo M; Setoain J; Tolosa E
    Eur J Nucl Med; 1996 Oct; 23(10):1329-37. PubMed ID: 8781137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative approach to technetium-99m ethyl cysteinate dimer: a comparison with technetium-99m hexamethylpropylene amine oxime.
    Matsuda H; Yagishita A; Tsuji S; Hisada K
    Eur J Nucl Med; 1995 Jul; 22(7):633-7. PubMed ID: 7498224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of cerebral blood flow in diabetic patients with no clinical history of neurological disease.
    Jimenez-Bonilla JF; Carril JM; Quirce R; Gomez-Barquin R; Amado JA; Gutierrez-Mendiguchia C
    Nucl Med Commun; 1996 Sep; 17(9):790-4. PubMed ID: 8895906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain single-photon emission tomography with technetium-99m hexamethylpropylene amine oxime in adolescents with initial-stage schizophrenia.
    Batista JF; Galiano MC; Torres LA; Hernández MC; Sosa F; Perera A; Pérez M
    Eur J Nucl Med; 1995 Nov; 22(11):1274-7. PubMed ID: 8575476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative technetium 99m hexamethylpropylene amine oxime SPET study in different types of dementia.
    Habert MO; Spampinato U; Mas JL; Piketty ML; Bourdel MC; de Recondo J; Rondot P; Askienazy S
    Eur J Nucl Med; 1991; 18(1):3-11. PubMed ID: 2019279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semi-quantitative assessment of cerebral blood flow with 99mTc-HMPAO SPET in type I diabetic patients with no clinical history of cerebrovascular disease.
    Quirce R; Carril JM; Jiménez-Bonilla JF; Amado JA; Gutiérrez-Mendiguchía C; Banzo I; Blanco I; Uriarte I; Montero A
    Eur J Nucl Med; 1997 Dec; 24(12):1507-13. PubMed ID: 9391186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional differences between 99mTc-ECD and 99mTc-HMPAO SPET in perfusion changes with age and gender in healthy adults.
    Inoue K; Nakagawa M; Goto R; Kinomura S; Sato T; Sato K; Fukuda H
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1489-97. PubMed ID: 14579088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular dementia of Binswanger's type: clinical, neuroradiological and 99mTc-HMPAO SPET study.
    Shyu WC; Lin JC; Shen CC; Hsu YD; Lee CC; Shiah IS; Tsao WL
    Eur J Nucl Med; 1996 Oct; 23(10):1338-44. PubMed ID: 8781138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional cerebral blood flow in IDDM patients: effects of diabetes and of recurrent severe hypoglycaemia.
    MacLeod KM; Hepburn DA; Deary IJ; Goodwin GM; Dougall N; Ebmeier KP; Frier BM
    Diabetologia; 1994 Mar; 37(3):257-63. PubMed ID: 8174839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-beta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease.
    Donnemiller E; Heilmann J; Wenning GK; Berger W; Decristoforo C; Moncayo R; Poewe W; Ransmayr G
    Eur J Nucl Med; 1997 Mar; 24(3):320-5. PubMed ID: 9143472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of changes in regional cerebral blood flow in patients with major depression using the 99mTc-HMPAO single photon emission tomography method.
    Yazici KM; Kapucu O; Erbas B; Varoglu E; Gülec C; Bekdik CF
    Eur J Nucl Med; 1992; 19(12):1038-43. PubMed ID: 1464356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multi-institutional study of interobserver agreement in the evaluation of dementia with rCBF/SPET technetium-99m exametazime (HMPAO).
    Hellman RS; Tikofsky RS; Van Heertum R; Coade G; Carretta R; Hoffmann RG
    Eur J Nucl Med; 1994 Apr; 21(4):306-13. PubMed ID: 8005154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of cerebral perfusion with single-photon emission tomography in normal subjects and in patients with Alzheimer's disease: effects of region of interest selection.
    Claus JJ; van Harskamp F; Breteler MM; Krenning EP; van der Cammen TJ; Hofman A; Hasan D
    Eur J Nucl Med; 1994 Oct; 21(10):1044-51. PubMed ID: 7828613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of aging on the cerebral distribution of technetium-99m hexamethylpropylene amine oxime in healthy humans.
    Mozley PD; Sadek AM; Alavi A; Gur RC; Muenz LR; Bunow BJ; Kim HJ; Stecker MH; Jolles P; Newberg A
    Eur J Nucl Med; 1997 Jul; 24(7):754-61. PubMed ID: 9211761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parameters influencing SPET regional brain uptake of technetium-99m hexamethylpropylene amine oxine measured by calibrated point sources as an external standard.
    Dierckx RA; Dobbeleir A; Maes M; Pickut BA; Vervaet A; De Deyn PP
    Eur J Nucl Med; 1994 Jun; 21(6):514-20. PubMed ID: 8082666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increment of brain temporal perfusion during auditory stimulation. Preliminary study with technetium-99m HMPAO SPET.
    Le Scao Y; Baulieu JL; Robier A; Pourcelot L; Beutter P
    Eur J Nucl Med; 1991; 18(12):981-3. PubMed ID: 1778211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of cerebral perfusion and cerebrovascular reserve in insulin-dependent diabetic patients without central neurological symptoms by means of 99mTc-HMPAO SPET with acetazolamide.
    Jiménez-Bonilla JF; Quirce R; Hernández A; Vallina NK; Guede C; Banzo I; Amado JA; Carril JM
    Eur J Nucl Med; 2001 Nov; 28(11):1647-55. PubMed ID: 11702106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.